Product References
Interferon-Induced Transmembrane Protein 3 Inhibits Hantaan Virus Infection, and Its Single Nucleotide Polymorphism rs12252 Influences the Severity of Hemorrhagic Fever with Renal Syndrome.
Frontiers in immunology
Xu-Yang Z,Pei-Yu B,Chuan-Tao Y,Wei Y,Hong-Wei M,Kang T,Chun-Mei Z,Ying-Feng L,Xin W,Ping-Zhong W,Chang-Xing H,Xue-Fan B,Ying Z,Zhan-Sheng J
Thu Mar 31 00:00:00 EDT 2022
Interferon-Induced Transmembrane Protein 3 Inhibits Hantaan Virus Infection, and Its Single Nucleotide Polymorphism rs12252 Influences the Severity of Hemorrhagic Fever with Renal Syndrome.
Frontiers in immunology
Xu-Yang Z,Pei-Yu B,Chuan-Tao Y,Wei Y,Hong-Wei M,Kang T,Chun-Mei Z,Ying-Feng L,Xin W,Ping-Zhong W,Chang-Xing H,Xue-Fan B,Ying Z,Zhan-Sheng J
Thu Mar 31 00:00:00 EDT 2022
IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
mBio
Ahi YS,Yimer D,Shi G,Majdoul S,Rahman K,Rein A,Compton AA
Tue Jan 21 00:00:00 EST 2020
Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.
Frontiers in immunology
Wang B,Lam TH,Soh MK,Ye Z,Chen J,Ren EC
Fri Aug 16 00:00:00 EDT 2019
Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.
Frontiers in immunology
Wang B,Lam TH,Soh MK,Ye Z,Chen J,Ren EC
Fri Aug 16 00:00:00 EDT 2019
Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.
Frontiers in immunology
Wang B,Lam TH,Soh MK,Ye Z,Chen J,Ren EC
Fri Aug 16 00:00:00 EDT 2019
Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay.
International journal of molecular sciences
Winkler M,Wrensch F,Bosch P,Knoth M,Schindler M,Gärtner S,Pöhlmann S
Thu Aug 08 00:00:00 EDT 2019
IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise.
Science (New York, N.Y.)
Buchrieser J,Degrelle SA,Couderc T,Nevers Q,Disson O,Manet C,Donahue DA,Porrot F,Hillion KH,Perthame E,Arroyo MV,Souquere S,Ruigrok K,Dupressoir A,Heidmann T,Montagutelli X,Fournier T,Lecuit M,Schwartz O
Fri Jul 12 00:00:00 EDT 2019
IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise.
Science (New York, N.Y.)
Buchrieser J,Degrelle SA,Couderc T,Nevers Q,Disson O,Manet C,Donahue DA,Porrot F,Hillion KH,Perthame E,Arroyo MV,Souquere S,Ruigrok K,Dupressoir A,Heidmann T,Montagutelli X,Fournier T,Lecuit M,Schwartz O
Fri Jul 12 00:00:00 EDT 2019
Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells.
Cell stem cell
Petrillo C,Thorne LG,Unali G,Schiroli G,Giordano AMS,Piras F,Cuccovillo I,Petit SJ,Ahsan F,Noursadeghi M,Clare S,Genovese P,Gentner B,Naldini L,Towers GJ,Kajaste-Rudnitski A
Thu Dec 06 00:00:00 EST 2018
mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
Proceedings of the National Academy of Sciences of the United States of America
Shi G,Ozog S,Torbett BE,Compton AA
Tue Oct 23 00:00:00 EDT 2018
IFITM proteins inhibit HIV-1 protein synthesis.
Scientific reports
Lee WJ,Fu RM,Liang C,Sloan RD
Fri Sep 28 00:00:00 EDT 2018
A CRISPR screen for factors regulating SAMHD1 degradation identifies IFITMs as potent inhibitors of lentiviral particle delivery.
Retrovirology
Roesch F,OhAinle M,Emerman M
Tue Mar 20 00:00:00 EDT 2018
Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.
Science translational medicine
Selman M,Ou P,Rousso C,Bergeron A,Krishnan R,Pikor L,Chen A,Keller BA,Ilkow C,Bell JC,Diallo JS
Wed Jan 24 00:00:00 EST 2018
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.
Molecular therapy : the journal of the American Society of Gene Therapy
Selman M,Rousso C,Bergeron A,Son HH,Krishnan R,El-Sayes NA,Varette O,Chen A,Le Boeuf F,Tzelepis F,Bell JC,Crans DC,Diallo JS
Wed Jan 03 00:00:00 EST 2018
Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy.
PloS one
Burchill MA,Roby JA,Crochet N,Wind-Rotolo M,Stone AE,Edwards MG,Dran RJ,Kriss MS,Gale M,Rosen HR
Tue Oct 24 00:00:00 EDT 2017
Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.
The EMBO journal
Monel B,Compton AA,Bruel T,Amraoui S,Burlaud-Gaillard J,Roy N,Guivel-Benhassine F,Porrot F,Génin P,Meertens L,Sinigaglia L,Jouvenet N,Weil R,Casartelli N,Demangel C,Simon-Lorière E,Moris A,Roingeard P,Amara A,Schwartz O
Wed Jun 14 00:00:00 EDT 2017
IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.
JCI insight
Raposo RAS,de Mulder Rougvie M,Paquin-Proulx D,Brailey PM,Cabido VD,Zdinak PM,Thomas AS,Huang SH,Beckerle GA,Jones RB,Nixon DF
Thu Jan 12 00:00:00 EST 2017
The IFITMs Inhibit Zika Virus Replication.
Cell reports
Savidis G,Perreira JM,Portmann JM,Meraner P,Guo Z,Green S,Brass AL
Tue Jun 14 00:00:00 EDT 2016
Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approach.
Clinical epigenetics
Gao F,Liang H,Lu H,Wang J,Xia M,Yuan Z,Yao Y,Wang T,Tan X,Laurence A,Xu H,Yu J,Xiao W,Chen W,Zhou M,Zhang X,Chen Q,Chen X
Mon Aug 24 00:00:00 EDT 2015
Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.
Journal of virology
Xie M,Xuan B,Shan J,Pan D,Sun Y,Shan Z,Zhang J,Yu D,Li B,Qian Z
Sun Mar 01 00:00:00 EST 2015
Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.
Journal of virology
Xie M,Xuan B,Shan J,Pan D,Sun Y,Shan Z,Zhang J,Yu D,Li B,Qian Z
Sun Mar 01 00:00:00 EST 2015
Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins.
The Journal of general virology
Zhang W,Zhang L,Zan Y,Du N,Yang Y,Tien P
Thu Jan 01 00:00:00 EST 2015
Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins.
The Journal of general virology
Zhang W,Zhang L,Zan Y,Du N,Yang Y,Tien P
Thu Jan 01 00:00:00 EST 2015
IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection.
Cellular microbiology
Zhu X,He Z,Yuan J,Wen W,Huang X,Hu Y,Lin C,Pan J,Li R,Deng H,Liao S,Zhou R,Wu J,Li J,Li M
Thu Jan 01 00:00:00 EST 2015
IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Cell host & microbe
Compton AA,Bruel T,Porrot F,Mallet A,Sachse M,Euvrard M,Liang C,Casartelli N,Schwartz O
Wed Dec 10 00:00:00 EST 2014
IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Cell host & microbe
Compton AA,Bruel T,Porrot F,Mallet A,Sachse M,Euvrard M,Liang C,Casartelli N,Schwartz O
Wed Dec 10 00:00:00 EST 2014
IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Retrovirology
Tartour K,Appourchaux R,Gaillard J,Nguyen XN,Durand S,Turpin J,Beaumont E,Roch E,Berger G,Mahieux R,Brand D,Roingeard P,Cimarelli A
Tue Nov 25 00:00:00 EST 2014
IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms.
Viruses
Wrensch F,Winkler M,Pöhlmann S
Fri Sep 26 00:00:00 EDT 2014
Interferon induction of IFITM proteins promotes infection by human coronavirus OC43.
Proceedings of the National Academy of Sciences of the United States of America
Zhao X,Guo F,Liu F,Cuconati A,Chang J,Block TM,Guo JT
Tue May 06 00:00:00 EDT 2014
Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.
Cell reports
Lin TY,Chin CR,Everitt AR,Clare S,Perreira JM,Savidis G,Aker AM,John SP,Sarlah D,Carreira EM,Elledge SJ,Kellam P,Brass AL
Wed Nov 27 00:00:00 EST 2013
The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Journal of virology
John SP,Chin CR,Perreira JM,Feeley EM,Aker AM,Savidis G,Smith SE,Elia AE,Everitt AR,Vora M,Pertel T,Elledge SJ,Kellam P,Brass AL
Mon Jul 01 00:00:00 EDT 2013
IFITM1 is a tight junction protein that inhibits hepatitis C virus entry.
Hepatology (Baltimore, Md.)
Wilkins C,Woodward J,Lau DT,Barnes A,Joyce M,McFarlane N,McKeating JA,Tyrrell DL,Gale M
Fri Feb 01 00:00:00 EST 2013
IFITM1 is a tight junction protein that inhibits hepatitis C virus entry.
Hepatology (Baltimore, Md.)
Wilkins C,Woodward J,Lau DT,Barnes A,Joyce M,McFarlane N,McKeating JA,Tyrrell DL,Gale M
Fri Feb 01 00:00:00 EST 2013
Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection.
Gastroenterology
Lau DT,Negash A,Chen J,Crochet N,Sinha M,Zhang Y,Guedj J,Holder S,Saito T,Lemon SM,Luxon BA,Perelson AS,Gale M
Fri Feb 01 00:00:00 EST 2013
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Cell
Brass AL,Huang IC,Benita Y,John SP,Krishnan MN,Feeley EM,Ryan BJ,Weyer JL,van der Weyden L,Fikrig E,Adams DJ,Xavier RJ,Farzan M,Elledge SJ
Thu Dec 24 00:00:00 EST 2009